Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

568 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
When is off-label off-road?
de Vries EGE, Cherny NI, Voest EE. de Vries EGE, et al. Ann Oncol. 2019 Oct 1;30(10):1536-1538. doi: 10.1093/annonc/mdz445. Ann Oncol. 2019. PMID: 31688929 Free PMC article. No abstract available.
ESMO-Magnitude of Clinical Benefit Scale version 1.1.
Cherny NI, Dafni U, Bogaerts J, Latino NJ, Pentheroudakis G, Douillard JY, Tabernero J, Zielinski C, Piccart MJ, de Vries EGE. Cherny NI, et al. Among authors: de vries ege. Ann Oncol. 2017 Oct 1;28(10):2340-2366. doi: 10.1093/annonc/mdx310. Ann Oncol. 2017. PMID: 28945867 Free article.
When is off-label off-road?
de Vries EGE, Cherny NI, Voest EE. de Vries EGE, et al. Ann Oncol. 2019 Dec 1;30(12):2018. doi: 10.1093/annonc/mdz455. Ann Oncol. 2019. PMID: 31893487 Free PMC article. No abstract available.
Reply to the letter to the editor 'The ESMO Magnitude of Clinical Benefit Scaling Tool: from theory to practice' by Hartmann and the letter 'Comment on ESMO Magnitude of Clinical Benefit Scale' by Muhonen et al.
Cherny NI, Sullivan R, Dafni U, Kerst JM, Sobrero A, Zielinski C, de Vries EGE, Piccart MJ. Cherny NI, et al. Among authors: de vries ege. Ann Oncol. 2016 Jan;27(1):205-207. doi: 10.1093/annonc/mdv502. Epub 2019 Dec 4. Ann Oncol. 2016. PMID: 32645815 No abstract available.
Efficacy of high-dose alkylating chemotherapy in HER2/neu-negative breast cancer.
Rodenhuis S, Bontenbal M, van Hoesel QG, Smit WM, Nooij MA, Voest EE, van der Wall E, Hupperets P, van Tinteren H, Peterse JL, van de Vijver MJ, de Vries EG; Netherlands Working Party on Autologous Transplantation in Solid Tumours. Rodenhuis S, et al. Ann Oncol. 2006 Apr;17(4):588-96. doi: 10.1093/annonc/mdl001. Epub 2006 Jan 30. Ann Oncol. 2006. PMID: 16446318 Free article. Clinical Trial.
568 results